Skip to main content
. 2022 Apr 7;11(8):2079. doi: 10.3390/jcm11082079

Figure 2.

Figure 2

(A) The SARC-F score in patients with the GS non-decline (n = 311) and the GS decline (n = 291). (B) The percentage of the SARC-F score ≥ 4 in patients with the GS non-decline and the GS decline.